PMID- 28043975
OWN - NLM
STAT- MEDLINE
DCOM- 20180910
LR  - 20180910
IS  - 1522-9645 (Electronic)
IS  - 0195-668X (Linking)
VI  - 38
IP  - 14
DP  - 2017 Apr 7
TI  - The year in cardiology 2016: coronary interventions.
PG  - 1017-1027
LID - 10.1093/eurheartj/ehw649 [doi]
FAU - Di Mario, Carlo
AU  - Di Mario C
AD  - Structural Interventional Cardiology Division, Careggi University Hospital, Largo
      Brambilla 3, 50134 Florence, Italy.
AD  - National Heart and Lung Institute, Imperial College, Sydney Street, Chelsea,
      London SW3 6NP, London.
FAU - Sorini Dini, Carlotta
AU  - Sorini Dini C
AD  - Structural Interventional Cardiology Division, Careggi University Hospital, Largo
      Brambilla 3, 50134 Florence, Italy.
FAU - Wijns, William
AU  - Wijns W
AD  - Lambe Institute for Translational Medicine and Curam, National University of
      Ireland, Galway and Saolta University Healthcare Group, University Road, Galway, 
      Ireland.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - England
TA  - Eur Heart J
JT  - European heart journal
JID - 8006263
RN  - 0 (Fibrinolytic Agents)
RN  - 0 (Platelet Aggregation Inhibitors)
RN  - 0 (Purinergic P2Y Receptor Antagonists)
RN  - G89JQ59I13 (Prasugrel Hydrochloride)
RN  - GLH0314RVC (Ticagrelor)
RN  - K72T3FS567 (Adenosine)
SB  - IM
MH  - Absorbable Implants
MH  - Acute Coronary Syndrome/surgery
MH  - Adenosine/analogs & derivatives/therapeutic use
MH  - Aftercare
MH  - Aged, 80 and over
MH  - Cardiac Imaging Techniques/methods
MH  - Coronary Angiography/methods
MH  - Coronary Artery Bypass/methods
MH  - Coronary Disease/*surgery
MH  - Diabetic Angiopathies/surgery
MH  - Drug Therapy, Combination
MH  - Fibrinolytic Agents/therapeutic use
MH  - Fractional Flow Reserve, Myocardial/physiology
MH  - Graft Occlusion, Vascular/prevention & control
MH  - Humans
MH  - Out-of-Hospital Cardiac Arrest/surgery
MH  - Percutaneous Coronary Intervention/*methods
MH  - Platelet Aggregation Inhibitors/therapeutic use
MH  - Practice Guidelines as Topic
MH  - Prasugrel Hydrochloride/therapeutic use
MH  - Prosthesis Design
MH  - Purinergic P2Y Receptor Antagonists/therapeutic use
MH  - Randomized Controlled Trials as Topic
MH  - ST Elevation Myocardial Infarction/surgery
MH  - Stents
MH  - Thrombectomy/methods
MH  - Time-to-Treatment
MH  - Tissue Scaffolds
EDAT- 2017/01/04 06:00
MHDA- 2018/09/11 06:00
CRDT- 2017/01/04 06:00
PHST- 2016/11/07 00:00 [received]
PHST- 2017/01/04 06:00 [pubmed]
PHST- 2018/09/11 06:00 [medline]
PHST- 2017/01/04 06:00 [entrez]
AID - ehw649 [pii]
AID - 10.1093/eurheartj/ehw649 [doi]
PST - ppublish
SO  - Eur Heart J. 2017 Apr 7;38(14):1017-1027. doi: 10.1093/eurheartj/ehw649.